Demant Earnings: No Material Surprises; Shares Are Expensive
Demant's release of third-quarter results on Nov. 3 held no major surprises after the preliminary trading update released Oct. 9. Full-year guidance was reaffirmed.
Demant's release of third-quarter results on Nov. 3 held no major surprises after the preliminary trading update released Oct. 9. Full-year guidance was reaffirmed.
Demant’s strong product pipeline, led by the global rollout of Oticon Zeal in 2026, will likely result in above-market growth in the next few years.
Demant has underperformed Sonova over the last two years in hearing aids. Sonova was the first to introduce real-time AI implementation, taking share from Demant.
Metric | DEMANT | SOON |
|---|---|---|
Price/Earnings (Normalized) | 28.33 | 25.40 |
Price/Book Value | 6.50 | 6.14 |
Price/Sales | 2.97 | 4.72 |
Price/Cash Flow | 17.10 | 18.56 |
Metric | DEMANT | SOON |
|---|---|---|
Quick Ratio | 0.54 | 0.97 |
Current Ratio | 0.82 | 1.69 |
Interest Coverage | 6.70 | 50.03 |
Metric | DEMANT | SOON |
|---|---|---|
Return on Assets (Normalized) | 6.76% | 12.48% |
Return on Equity (Normalized) | 24.80% | 27.19% |
Return on Invested Capital (Normalized) | 9.75% | 20.95% |
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|Y#?NwT< | LOCK|%v?S> | $186B | |||
| Medtronic PLC MDT | LOCK|DK<>>tN | LOCK|v>Y# | $132B | |||
| Stryker Corp SYK | LOCK|#&r#QHT< | LOCK|!D | $118B | |||
| Boston Scientific Corp BSX | LOCK|^$LJ<P | LOCK|&&>>b | $63B | |||
| Edwards Lifesciences Corp EW | LOCK|GW>Zh>D | LOCK|cD&^l | $62B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|Hcx%$M | LOCK|&h | $38B | |||
| DexCom Inc DXCM | LOCK|HF!p$#tF | LOCK|mZ>jy | $30B | |||
| Koninklijke Philips NV ADR PHG | LOCK|HT | LOCK|@h! | $30B | |||
| Steris PLC STE | LOCK|%^y>ZR | LOCK|dH?$j | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|l$&k!<?$ | LOCK|l@ | $19B |